A Trial of Tegileridine Fumarate Lnjection for Prolonged Mechanical Ventilation Abirritation in the Intensive Care Unit (ICU)

by palligoelme@gmail.com | Jan 28, 2026 | Clinical Trials

​ Conditions: Abirritation in the ICU Interventions: Drug: Tegileridine Fumarate lnjection; Drug: Tegileridine Fumarate lnjection; Drug: Remifentanil Hydrochloride for Injection Sponsors: Jiangsu HengRui Medicine Co., Ltd. Not yet recruiting Conditions: Abirritation...

CHRONO-NUTRITION APPLICATION: THE EFFECT OF FIBER JELLY ON POST PRANDIAL BLOOD GLUCOSE, SATIETY AND WEIGHT LOSS AMONG OVERWEIGHT WOMEN

by palligoelme@gmail.com | Jan 28, 2026 | Clinical Trials

​ Conditions: Overweight and Obese Adults Interventions: Combination Product: Fiber jelly Sponsors: Surabaya State University Completed Conditions: Overweight and Obese Adults Interventions: Combination Product: Fiber jelly Sponsors: Surabaya State University...

Effect of Perineal Massage on the Frequency of Episiotomy and Perineal Tearing

by palligoelme@gmail.com | Jan 28, 2026 | Clinical Trials

​ Conditions: Episiotomy Extended by Laceration Interventions: Procedure: Intrapartum perineal massage; Other: Standard Intrapartum Care Group (Control) Sponsors: Sheikh Zayed Medical College Active, not recruiting Conditions: Episiotomy Extended by Laceration...

A Phase III Study of CM326 in Subjects With Moderate to Severe Asthma

by palligoelme@gmail.com | Jan 28, 2026 | Clinical Trials

​ Conditions: Moderate to Severe Asthma Interventions: Drug: CM326; Other: Placebo Sponsors: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Not yet recruiting Conditions: Moderate to Severe Asthma Interventions: Drug: CM326; Other: Placebo Sponsors: CSPC Baike...

Prognostic Model of Elderly Hodgkin Lymphoma in China

by palligoelme@gmail.com | Jan 28, 2026 | Clinical Trials

​ Conditions: Hodgkin Lymphoma Sponsors: Tianjin Medical University Cancer Institute and Hospital Active, not recruiting Conditions: Hodgkin Lymphoma Sponsors: Tianjin Medical University Cancer Institute and Hospital Active, not...

A Prospective, Single-arm, Exploratory Study of Trifluridine/Tipiracil (TAS-102) Combined With Apatinib as Third-line Therapy for Advanced Gastric Cancer

by palligoelme@gmail.com | Jan 28, 2026 | Clinical Trials

​ Conditions: Advanced Gastric Cancer Interventions: Drug: Trifluridine/Tipiracil (TAS-102) combined with Apatinib Sponsors: Anhui Provincial Cancer Hospital Not yet recruiting Conditions: Advanced Gastric Cancer Interventions: Drug: Trifluridine/Tipiracil (TAS-102)...